Chronic myeloid leukemia lysate-loaded dendritic cells induce T-cell responses towards leukemia progenitor cells
/in Chronic Leukemia, Dendritic Cells, International Publications /von 2011-04-01 / Immunotherapy 2011 Apr;3(4):569-76Third generation dendritic cell vaccines for tumor immunotherapy
/in Dendritic Cells, International Publications /von 2011-03-25 / Eur. J. Cell Biol. 2012 Jan;91(1):53-8Targeting of IL-2 and GM-CSF immunocytokines to a tumor vaccine leads to increased anti-tumor activity
/in Dendritic Cells, International Publications, IOZK Veröffentlichungen, Newcastle Disease Virus /von 2011-03-17 / Int. J. Oncol. 2011 Jun;38(6):1719-29hTERT mRNA dendritic cell vaccination: complete response in a pancreatic cancer patient associated with response against several hTERT epitopes
/in Dendritic Cells, International Publications /von 2011-03-02 / Cancer Immunol. Immunother. 2011 Jun;60(6):809-18Changes in peripheral blood level of regulatory T cells in patients with malignant melanoma during treatment with dendritic cell vaccination and low-dose IL-2
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2011-03-01 / Scand. J. Immunol. 2011 Mar;73(3):222-33Exosome-loaded dendritic cells elicit tumor-specific CD8+ cytotoxic T cells in patients with glioma
/in Dendritic Cells, Exosome, Glioblastoma, International Publications /von 2011-02-19 / J. Neurooncol. 2011 Sep;104(3):659-67Phase I/II trial of a dendritic cell vaccine transfected with DNA encoding melan A and gp100 for patients with metastatic melanoma
/in Dendritic Cells, International Publications, Malignant Melanoma /von 2011-02-10 / Gene Ther. 2011 Jun;18(6):584-93IL-15 and type I interferon are required for activation of tumoricidal NK cells by virus-infected dendritic cells
/in Dendritic Cells, International Publications, Newcastle Disease Virus /von 2011-02-09 / Cancer Res. 2011 Apr;71(7):2497-506Heat-shock induction of tumor-derived danger signals mediates rapid monocyte differentiation into clinically effective dendritic cells
/in Dendritic Cells, Hyperthermia, International Publications /von 2011-02-03 / Clin. Cancer Res. 2011 Apr;17(8):2474-83
IMMUN-ONKOLOGISCHES ZENTRUM KÖLN
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de
Hohenstaufenring 30–32
50674 Köln | Deutschland
T: +49 (0)221 – 420 399 25
E-Mail: info@iozk.de